Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,059 public trials 1,846 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Active, not recruiting

Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT03909334

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +15 more
Locations
  • Georgetown University Washington D.C., District of Columbia, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
  • Rush University Medical Center Chicago, Illinois, United States
View Trial Details
Active, not recruiting

Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study

NCT05633602

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
View all 566 locations
View Trial Details
Active, not recruiting

A Single-arm Trial of Atezolizumab/Platinum/Etoposide for the Treatment of Advanced Large-cell Neuroendocrine Cancer of the Lung

NCT05470595

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +14 more
Locations
  • Charité - Universitätsklinikum Berlin Centrum 12, Medizinische Klinik Berlin, Germany
  • Evangelische Lungenklinik Berlin, Germany
  • Klinikum der Universität zu Köln, Klinik I für Innere Medizin Cologne, Germany
  • Universitätsklinikum Dresden, Medizinische Klinik 1 Dresden, Germany
View all 15 locations
View Trial Details
Active, not recruiting

A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer

NCT05635708

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center Mskcc New York, United States
  • Providence Portland Medical Center Portland, Oregon, United States
View all 61 locations
View Trial Details

Related conditions